Clinical Trial Update: A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650) [Phase 1]

View source ↗

Summary

This update reports the completed Phase 1, placebo-controlled trial of INS117548 ophthalmic solution in subjects with glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• INS117548

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Glaucoma | Phase 1 | Status: COMPLETED